Dr. Peter McAllister
Claim this profileNew England Institute for Clinical Research
Studies Migraine
Studies Alzheimer's Disease
18 reported clinical trials
16 drugs studied
About Peter McAllister
Education:
- Earned an MD from the University of Connecticut School of Medicine in 1987.
Experience:
- Board-certified neurologist with over three decades of experience.
- Serves as Medical Director at the New England Institute for Clinical Research (NEICR).
- Founded the New England Institute of Neurology and Headache (NEINH), where he is also the Chief Medical Officer.
- Has held academic positions at Yale University School of Medicine and the University of Connecticut School of Medicine.
Affiliated Hospitals
Clinical Trials Peter McAllister is currently running
Lasmiditan
for Pediatric Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
Recruiting2 awards Phase 3
Galcanezumab
for Migraine
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Recruiting1 award Phase 31 criteria
More about Peter McAllister
Clinical Trial Related5 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Peter McAllister has experience with
- Placebo
- Lasmiditan
- ABP-450
- CT1812
- Buntanetap
- Galcanezumab
Breakdown of trials Peter McAllister has run
Migraine
Alzheimer's Disease
Vestibular Migraine
Dementia
Cognitive Impairment
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter McAllister specialize in?
Peter McAllister focuses on Migraine and Alzheimer's Disease. In particular, much of their work with Migraine has involved treating patients, or patients who are undergoing treatment.
Is Peter McAllister currently recruiting for clinical trials?
Yes, Peter McAllister is currently recruiting for 6 clinical trials in Stamford Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Peter McAllister has studied deeply?
Yes, Peter McAllister has studied treatments such as Placebo, Lasmiditan, ABP-450.
What is the best way to schedule an appointment with Peter McAllister?
Apply for one of the trials that Peter McAllister is conducting.
What is the office address of Peter McAllister?
The office of Peter McAllister is located at: New England Institute for Clinical Research, Stamford, Connecticut 06905 United States. This is the address for their practice at the New England Institute for Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.